USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 15:00 PM 2012

NYSE 8091.04 8.06 Index Moved Up

NASDAQ 2928.09 12.23 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for CRM and MRK...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salesforce.com Inc Common Stoc and

Merck & Company Inc. Comm

Volatility

Matrix

Run Correlation

Diversification

Weak diversification

Overlapping area represents amount of risk that can be diversified away by holding Salesforce.com Inc Common Stoc and Merck & Company Inc. Comm in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.32

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Suggest

Salesforce.com Inc Common Stock

Profile

126.74

Intraday

One Month

^2.94

2.37%

CRM

NYSE

Salesforce.com Inc Common Stoc

P/E	8253.33	Day Low	123.13
Open	123.42	P/B Ratio	11.24
Market Cap	17.237B	Volume	1760307
Sector	Technology	Last Close	123.80
Short Ratio	4.00	Last Traded	2/9/2012
Year High	160.12	Percent Change	2.37%
EBITDA	90.9M	Year Low	94.09
Absolute Change	2.94	Time	Not Applicable
Book Value	11.018	EPS	0.015
PEG Ratio	3.76	Employees	5,306
Day High	127.70	Industry	Application Software
Target Price	147.70	Current EPS	0.015
This Year EPS	1.33	Next Year EPS	1.63
Current PE	8253.33	This Year PE	93.08
Next Year PE	75.95	Dividend	Not Applicable

Merck & Company Inc. Common St

Profile

38.27

Intraday

One Month

^(0.16)

0.40%

MRK

NYSE

Merck & Company Inc. Comm

P/E	19.00	Day Low	38.14
Open	38.39	P/B Ratio	2.13
Market Cap	116.6B	Volume	5854331
Sector	Healthcare	Last Close	38.42
Short Ratio	2.10	Last Traded	2/9/2012
Year High	39.43	Percent Change	0.40%
EBITDA	17.398B	Year Low	29.47
Absolute Change	0.16	Time	Not Applicable
Book Value	18.067	EPS	2.022
PEG Ratio	2.78	Employees	86,000
Day High	38.52	Industry	Drug Manufacturers -
Target Price	40.79	Current EPS	2.022
This Year EPS	3.81	Next Year EPS	3.72
Current PE	19.00	This Year PE	10.08
Next Year PE	10.33	Dividend	1.56
Dividend Yield	4.06	Dividend Date	Jan 9